high
Buy
20,000 shares
$240,000
Significance
7/10
CEO Michael Nally purchased 20,000 shares of GENB at $12.00 on 2026-03-04; cluster of 4 other insider buys in 14 days
Michael Nally, CEO of Generate Biomedicines, acquired 20,000 shares at $12.00, increasing his holdings from 552,707 shares to 572,707 shares (+3.6%). The transaction occurred just 6 trading days after the company's recent listing, a period when insider trading is highly scrutinized and selective. Notably, 4 other insiders also purchased within the past 14 days, forming a cluster buy pattern that suggests coordinated confidence during the company's early public market period. The current price of $11.21 is below his purchase price, placing this trade underwater as of 2026-03-06.